How to use Digital Twins for the prevention and interception of diseases? Opportunities to pioneer and pilot in Finland?
Wed 12 June 2019 at 12:15–13:15
Finland Pavilion Stage (Conference area, Messukeskus)
This session will discuss in detail the usage of Digital Twins in the transition from Disease Care to Health Care. Due to the enormous amount of health data in digital format and the homogenous genomic background of Finnish people Finland offers a unique environment globally to develop, test and pilot Digital Twins in the prevention and interception of diseases. Digital twins are built on computer-based, or in silico, models that are fed individual and population data, and they will help define a trajectory for health/disease and identify transitions on that trajectory.
- Patrick Loerch
Ph.D. VP, Global Head Data Sciences & Prevention Biomarkers, World Without Disease Accelerator, Janssen R&D
- Timo Miettinen
Information Systems Manager, Institute for Molecular Medicine Finland (FIMM)
- Markus Leskinen
Ph.D., MD, Neonatalogist, Helsinki University Hospital (HUS)
- Jukka Lähesmaa
Senior specialist, Finnish Ministry of Social and Health Affairs
- Juho Paaso
VP of Engineering, BC Platform
The panel discussion will be moderated by Marja-Liisa Niinikoski, CEO, Helsinki Business Hub.